Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00773812 · ClinicalTrials.gov registry record · Phase 1
Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders
A Phase 1 study, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
NCT00773812 is a Phase 1 study that has completed, run by Ohio State University. The registered enrollment target is 20 participants.
The verdict
NCT00773812, a Phase 1 study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the safety and efficacy of mecamylamine for the core symptoms of autism.
Interventions
- DRUG placebo
- DRUG mecamylamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-07 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00773812
The ClinicalTrials.gov registry entry for NCT00773812 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00773812 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00773812 about?
NCT00773812 is a clinical study titled "Placebo-Controlled Pilot Trial of Mecamylamine for Treatment of Autism Spectrum Disorders". The purpose of this study is to examine the safety and efficacy of mecamylamine for the core symptoms of autism.
What is the current status of trial NCT00773812?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2007-07. Estimated completion is 2012-11.
What interventions are being tested in trial NCT00773812?
The interventions under investigation include: placebo (DRUG), mecamylamine (DRUG).
Who is sponsoring clinical trial NCT00773812?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.